| Product Code: ETC5795238 | Publication Date: Nov 2023 | Updated Date: Aug 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Ravi Bhandari | No. of Pages: 60 | No. of Figures: 30 | No. of Tables: 5 |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Israel Human Milk Oligosaccharides (HMO) Market Overview |
3.1 Israel Country Macro Economic Indicators |
3.2 Israel Human Milk Oligosaccharides (HMO) Market Revenues & Volume, 2021 & 2031F |
3.3 Israel Human Milk Oligosaccharides (HMO) Market - Industry Life Cycle |
3.4 Israel Human Milk Oligosaccharides (HMO) Market - Porter's Five Forces |
3.5 Israel Human Milk Oligosaccharides (HMO) Market Revenues & Volume Share, By Type, 2021 & 2031F |
3.6 Israel Human Milk Oligosaccharides (HMO) Market Revenues & Volume Share, By Application, 2021 & 2031F |
3.7 Israel Human Milk Oligosaccharides (HMO) Market Revenues & Volume Share, By Concentration, 2021 & 2031F |
4 Israel Human Milk Oligosaccharides (HMO) Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing awareness about the health benefits of human milk oligosaccharides (HMOs) |
4.2.2 Growing demand for infant nutrition products with added functional ingredients |
4.2.3 Rising prevalence of infant health issues driving the use of specialized nutrition products |
4.3 Market Restraints |
4.3.1 High production costs associated with extracting and synthesizing HMOs |
4.3.2 Limited availability of HMO-enriched products in the market |
4.3.3 Regulatory challenges and approval processes for HMO-based products |
5 Israel Human Milk Oligosaccharides (HMO) Market Trends |
6 Israel Human Milk Oligosaccharides (HMO) Market Segmentations |
6.1 Israel Human Milk Oligosaccharides (HMO) Market, By Type |
6.1.1 Overview and Analysis |
6.1.2 Israel Human Milk Oligosaccharides (HMO) Market Revenues & Volume, By 2? ? Fl, 2021-2031F |
6.1.3 Israel Human Milk Oligosaccharides (HMO) Market Revenues & Volume, By 3? ? Fl, 2021-2031F |
6.1.4 Israel Human Milk Oligosaccharides (HMO) Market Revenues & Volume, By 3? ? Sl, 2021-2031F |
6.1.5 Israel Human Milk Oligosaccharides (HMO) Market Revenues & Volume, By 6? ? Sl, 2021-2031F |
6.2 Israel Human Milk Oligosaccharides (HMO) Market, By Application |
6.2.1 Overview and Analysis |
6.2.2 Israel Human Milk Oligosaccharides (HMO) Market Revenues & Volume, By Infant Formula, 2021-2031F |
6.2.3 Israel Human Milk Oligosaccharides (HMO) Market Revenues & Volume, By Functional Food & Beverages, 2021-2031F |
6.2.4 Israel Human Milk Oligosaccharides (HMO) Market Revenues & Volume, By Food Supplement, 2021-2031F |
6.3 Israel Human Milk Oligosaccharides (HMO) Market, By Concentration |
6.3.1 Overview and Analysis |
6.3.2 Israel Human Milk Oligosaccharides (HMO) Market Revenues & Volume, By Neutral, 2021-2031F |
6.3.3 Israel Human Milk Oligosaccharides (HMO) Market Revenues & Volume, By Acidic, 2021-2031F |
7 Israel Human Milk Oligosaccharides (HMO) Market Import-Export Trade Statistics |
7.1 Israel Human Milk Oligosaccharides (HMO) Market Export to Major Countries |
7.2 Israel Human Milk Oligosaccharides (HMO) Market Imports from Major Countries |
8 Israel Human Milk Oligosaccharides (HMO) Market Key Performance Indicators |
8.1 Research and Development (RD) investment in HMO technology and product development |
8.2 Number of new product launches featuring HMOs |
8.3 Adoption rate of HMO-enriched products among target consumers |
8.4 Level of collaboration between key industry players in advancing HMO market offerings |
8.5 Consumer perception and acceptance of the benefits of HMOs in infant nutrition |
9 Israel Human Milk Oligosaccharides (HMO) Market - Opportunity Assessment |
9.1 Israel Human Milk Oligosaccharides (HMO) Market Opportunity Assessment, By Type, 2021 & 2031F |
9.2 Israel Human Milk Oligosaccharides (HMO) Market Opportunity Assessment, By Application, 2021 & 2031F |
9.3 Israel Human Milk Oligosaccharides (HMO) Market Opportunity Assessment, By Concentration, 2021 & 2031F |
10 Israel Human Milk Oligosaccharides (HMO) Market - Competitive Landscape |
10.1 Israel Human Milk Oligosaccharides (HMO) Market Revenue Share, By Companies, 2024 |
10.2 Israel Human Milk Oligosaccharides (HMO) Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations | 13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here